Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.
Identifieur interne : 000191 ( PubMed/Checkpoint ); précédent : 000190; suivant : 000192Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.
Auteurs : Seyyed Mahmoud Ebrahimi [Iran] ; Majid Tebianian ; Hadi Toghyani ; Arash Memarnejadian ; Hamid Reza AttaranSource :
- Protein expression and purification [ 1096-0279 ] ; 2010.
Descripteurs français
- KwdFr :
- Animaux, Antigènes viraux (génétique), Antigènes viraux (immunologie), Antigènes viraux (métabolisme), Clonage moléculaire, Lapins, Mycobacterium tuberculosis (génétique), Pichia (génétique), Pichia (métabolisme), Protéines de fusion recombinantes (immunologie), Protéines de fusion recombinantes (isolement et purification), Protéines de fusion recombinantes (métabolisme), Protéines de la matrice virale (génétique), Protéines de la matrice virale (immunologie), Protéines de la matrice virale (métabolisme), Protéines du choc thermique HSP70 (génétique), Protéines du choc thermique HSP70 (métabolisme), Protéines recombinantes (métabolisme), Sous-type H9N2 du virus de la grippe A (métabolisme).
- MESH :
- génétique : Antigènes viraux, Mycobacterium tuberculosis, Pichia, Protéines de la matrice virale, Protéines du choc thermique HSP70.
- immunologie : Antigènes viraux, Protéines de fusion recombinantes, Protéines de la matrice virale.
- isolement et purification : Protéines de fusion recombinantes.
- métabolisme : Antigènes viraux, Pichia, Protéines de fusion recombinantes, Protéines de la matrice virale, Protéines du choc thermique HSP70, Protéines recombinantes, Sous-type H9N2 du virus de la grippe A.
- Animaux, Clonage moléculaire, Lapins.
English descriptors
- KwdEn :
- Animals, Antigens, Viral (genetics), Antigens, Viral (immunology), Antigens, Viral (metabolism), Cloning, Molecular, HSP70 Heat-Shock Proteins (genetics), HSP70 Heat-Shock Proteins (metabolism), Influenza A Virus, H9N2 Subtype (metabolism), Mycobacterium tuberculosis (genetics), Pichia (genetics), Pichia (metabolism), Rabbits, Recombinant Fusion Proteins (immunology), Recombinant Fusion Proteins (isolation & purification), Recombinant Fusion Proteins (metabolism), Recombinant Proteins (metabolism), Viral Matrix Proteins (genetics), Viral Matrix Proteins (immunology), Viral Matrix Proteins (metabolism).
- MESH :
- chemical , genetics : Antigens, Viral, HSP70 Heat-Shock Proteins, Viral Matrix Proteins.
- chemical , immunology : Antigens, Viral, Recombinant Fusion Proteins, Viral Matrix Proteins.
- chemical , isolation & purification : Recombinant Fusion Proteins.
- chemical , metabolism : Antigens, Viral, HSP70 Heat-Shock Proteins, Recombinant Fusion Proteins, Recombinant Proteins, Viral Matrix Proteins.
- genetics : Mycobacterium tuberculosis, Pichia.
- metabolism : Influenza A Virus, H9N2 Subtype, Pichia.
- Animals, Cloning, Molecular, Rabbits.
Abstract
Due to its conservation, the extracellular domain of the influenza A M2 protein (M2e) has the potential for being applied as a recombinant vaccine candidate against a wide range of strains, though its immunogenicity may need to be improved. The occurrence of several post-translational modifications within the structure of M2 protein may affect its immunopotency for the induction of humoral immune response. Herein, to construct a recombinant M2e-based vaccine candidate with the appropriate structural conformation and immunogenicity the corresponding nucleotide sequence from an H9N2 influenza strain was fused to the N-terminus of the truncated Mycobacterium tuberculosis HSP70(359-610), as a potent adjuvant, and following its cloning into the pPICZ alpha A plasmid the fusion gene was expressed in Pichia pastoris KM71H yeast. The secreted protein was then easily purified from the culture media, based on the presence of polyhistidine tag and used for the production of rabbit polyclonal antisera. This raised antisera could recognize the native M2e protein on the surface of H9N2 influenza virus-infected MDCK cells at a comparable level with the commercial H2N2-specific anti-M2 antibody, which was evidenced with immunofluorescence and cell-ELISA assays. These results not only re-emphasized on the conservancy of the M2e antigen, but also pointed towards the applicability of the M2e-HSP70(359-610) fusion protein for the induction of specific antibodies capable of binding to the native M2e antigen on the infected cells. Collectively, this study implied that purified M2e-HSP70(359-610) represents a promising vaccine candidate; however, its in vivo potency for the induction of protection remains to be evaluated.
DOI: 10.1016/j.pep.2009.11.001
PubMed: 19897044
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19897044Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.</title><author><name sortKey="Ebrahimi, Seyyed Mahmoud" sort="Ebrahimi, Seyyed Mahmoud" uniqKey="Ebrahimi S" first="Seyyed Mahmoud" last="Ebrahimi">Seyyed Mahmoud Ebrahimi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology, Razi Vaccine and Serum Research Institute (RVSRI), P.O. Box 31975/148, Karaj, Tehran, Iran. smebrahimi@shirazu.ac.ir</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Biotechnology, Razi Vaccine and Serum Research Institute (RVSRI), P.O. Box 31975/148, Karaj, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Tebianian, Majid" sort="Tebianian, Majid" uniqKey="Tebianian M" first="Majid" last="Tebianian">Majid Tebianian</name></author><author><name sortKey="Toghyani, Hadi" sort="Toghyani, Hadi" uniqKey="Toghyani H" first="Hadi" last="Toghyani">Hadi Toghyani</name></author><author><name sortKey="Memarnejadian, Arash" sort="Memarnejadian, Arash" uniqKey="Memarnejadian A" first="Arash" last="Memarnejadian">Arash Memarnejadian</name></author><author><name sortKey="Attaran, Hamid Reza" sort="Attaran, Hamid Reza" uniqKey="Attaran H" first="Hamid Reza" last="Attaran">Hamid Reza Attaran</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:19897044</idno><idno type="pmid">19897044</idno><idno type="doi">10.1016/j.pep.2009.11.001</idno><idno type="wicri:Area/PubMed/Corpus">000216</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000216</idno><idno type="wicri:Area/PubMed/Curation">000216</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000216</idno><idno type="wicri:Area/PubMed/Checkpoint">000191</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000191</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.</title><author><name sortKey="Ebrahimi, Seyyed Mahmoud" sort="Ebrahimi, Seyyed Mahmoud" uniqKey="Ebrahimi S" first="Seyyed Mahmoud" last="Ebrahimi">Seyyed Mahmoud Ebrahimi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology, Razi Vaccine and Serum Research Institute (RVSRI), P.O. Box 31975/148, Karaj, Tehran, Iran. smebrahimi@shirazu.ac.ir</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Biotechnology, Razi Vaccine and Serum Research Institute (RVSRI), P.O. Box 31975/148, Karaj, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Tebianian, Majid" sort="Tebianian, Majid" uniqKey="Tebianian M" first="Majid" last="Tebianian">Majid Tebianian</name></author><author><name sortKey="Toghyani, Hadi" sort="Toghyani, Hadi" uniqKey="Toghyani H" first="Hadi" last="Toghyani">Hadi Toghyani</name></author><author><name sortKey="Memarnejadian, Arash" sort="Memarnejadian, Arash" uniqKey="Memarnejadian A" first="Arash" last="Memarnejadian">Arash Memarnejadian</name></author><author><name sortKey="Attaran, Hamid Reza" sort="Attaran, Hamid Reza" uniqKey="Attaran H" first="Hamid Reza" last="Attaran">Hamid Reza Attaran</name></author></analytic><series><title level="j">Protein expression and purification</title><idno type="eISSN">1096-0279</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antigens, Viral (genetics)</term><term>Antigens, Viral (immunology)</term><term>Antigens, Viral (metabolism)</term><term>Cloning, Molecular</term><term>HSP70 Heat-Shock Proteins (genetics)</term><term>HSP70 Heat-Shock Proteins (metabolism)</term><term>Influenza A Virus, H9N2 Subtype (metabolism)</term><term>Mycobacterium tuberculosis (genetics)</term><term>Pichia (genetics)</term><term>Pichia (metabolism)</term><term>Rabbits</term><term>Recombinant Fusion Proteins (immunology)</term><term>Recombinant Fusion Proteins (isolation & purification)</term><term>Recombinant Fusion Proteins (metabolism)</term><term>Recombinant Proteins (metabolism)</term><term>Viral Matrix Proteins (genetics)</term><term>Viral Matrix Proteins (immunology)</term><term>Viral Matrix Proteins (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antigènes viraux (génétique)</term><term>Antigènes viraux (immunologie)</term><term>Antigènes viraux (métabolisme)</term><term>Clonage moléculaire</term><term>Lapins</term><term>Mycobacterium tuberculosis (génétique)</term><term>Pichia (génétique)</term><term>Pichia (métabolisme)</term><term>Protéines de fusion recombinantes (immunologie)</term><term>Protéines de fusion recombinantes (isolement et purification)</term><term>Protéines de fusion recombinantes (métabolisme)</term><term>Protéines de la matrice virale (génétique)</term><term>Protéines de la matrice virale (immunologie)</term><term>Protéines de la matrice virale (métabolisme)</term><term>Protéines du choc thermique HSP70 (génétique)</term><term>Protéines du choc thermique HSP70 (métabolisme)</term><term>Protéines recombinantes (métabolisme)</term><term>Sous-type H9N2 du virus de la grippe A (métabolisme)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Viral</term><term>HSP70 Heat-Shock Proteins</term><term>Viral Matrix Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Viral</term><term>Recombinant Fusion Proteins</term><term>Viral Matrix Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Recombinant Fusion Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antigens, Viral</term><term>HSP70 Heat-Shock Proteins</term><term>Recombinant Fusion Proteins</term><term>Recombinant Proteins</term><term>Viral Matrix Proteins</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mycobacterium tuberculosis</term><term>Pichia</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes viraux</term><term>Mycobacterium tuberculosis</term><term>Pichia</term><term>Protéines de la matrice virale</term><term>Protéines du choc thermique HSP70</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes viraux</term><term>Protéines de fusion recombinantes</term><term>Protéines de la matrice virale</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Protéines de fusion recombinantes</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Influenza A Virus, H9N2 Subtype</term><term>Pichia</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Antigènes viraux</term><term>Pichia</term><term>Protéines de fusion recombinantes</term><term>Protéines de la matrice virale</term><term>Protéines du choc thermique HSP70</term><term>Protéines recombinantes</term><term>Sous-type H9N2 du virus de la grippe A</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cloning, Molecular</term><term>Rabbits</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Clonage moléculaire</term><term>Lapins</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Due to its conservation, the extracellular domain of the influenza A M2 protein (M2e) has the potential for being applied as a recombinant vaccine candidate against a wide range of strains, though its immunogenicity may need to be improved. The occurrence of several post-translational modifications within the structure of M2 protein may affect its immunopotency for the induction of humoral immune response. Herein, to construct a recombinant M2e-based vaccine candidate with the appropriate structural conformation and immunogenicity the corresponding nucleotide sequence from an H9N2 influenza strain was fused to the N-terminus of the truncated Mycobacterium tuberculosis HSP70(359-610), as a potent adjuvant, and following its cloning into the pPICZ alpha A plasmid the fusion gene was expressed in Pichia pastoris KM71H yeast. The secreted protein was then easily purified from the culture media, based on the presence of polyhistidine tag and used for the production of rabbit polyclonal antisera. This raised antisera could recognize the native M2e protein on the surface of H9N2 influenza virus-infected MDCK cells at a comparable level with the commercial H2N2-specific anti-M2 antibody, which was evidenced with immunofluorescence and cell-ELISA assays. These results not only re-emphasized on the conservancy of the M2e antigen, but also pointed towards the applicability of the M2e-HSP70(359-610) fusion protein for the induction of specific antibodies capable of binding to the native M2e antigen on the infected cells. Collectively, this study implied that purified M2e-HSP70(359-610) represents a promising vaccine candidate; however, its in vivo potency for the induction of protection remains to be evaluated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19897044</PMID><DateCompleted><Year>2010</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2010</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0279</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Protein expression and purification</Title><ISOAbbreviation>Protein Expr. Purif.</ISOAbbreviation></Journal><ArticleTitle>Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.</ArticleTitle><Pagination><MedlinePgn>7-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pep.2009.11.001</ELocationID><Abstract><AbstractText>Due to its conservation, the extracellular domain of the influenza A M2 protein (M2e) has the potential for being applied as a recombinant vaccine candidate against a wide range of strains, though its immunogenicity may need to be improved. The occurrence of several post-translational modifications within the structure of M2 protein may affect its immunopotency for the induction of humoral immune response. Herein, to construct a recombinant M2e-based vaccine candidate with the appropriate structural conformation and immunogenicity the corresponding nucleotide sequence from an H9N2 influenza strain was fused to the N-terminus of the truncated Mycobacterium tuberculosis HSP70(359-610), as a potent adjuvant, and following its cloning into the pPICZ alpha A plasmid the fusion gene was expressed in Pichia pastoris KM71H yeast. The secreted protein was then easily purified from the culture media, based on the presence of polyhistidine tag and used for the production of rabbit polyclonal antisera. This raised antisera could recognize the native M2e protein on the surface of H9N2 influenza virus-infected MDCK cells at a comparable level with the commercial H2N2-specific anti-M2 antibody, which was evidenced with immunofluorescence and cell-ELISA assays. These results not only re-emphasized on the conservancy of the M2e antigen, but also pointed towards the applicability of the M2e-HSP70(359-610) fusion protein for the induction of specific antibodies capable of binding to the native M2e antigen on the infected cells. Collectively, this study implied that purified M2e-HSP70(359-610) represents a promising vaccine candidate; however, its in vivo potency for the induction of protection remains to be evaluated.</AbstractText><CopyrightInformation>(c) 2009 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Seyyed Mahmoud</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Razi Vaccine and Serum Research Institute (RVSRI), P.O. Box 31975/148, Karaj, Tehran, Iran. smebrahimi@shirazu.ac.ir</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebianian</LastName><ForeName>Majid</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Toghyani</LastName><ForeName>Hadi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Memarnejadian</LastName><ForeName>Arash</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Attaran</LastName><ForeName>Hamid Reza</ForeName><Initials>HR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Protein Expr Purif</MedlineTA><NlmUniqueID>9101496</NlmUniqueID><ISSNLinking>1046-5928</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018840">HSP70 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C488937">M2 protein, Influenza A virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018840" MajorTopicYN="N">HSP70 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053127" MajorTopicYN="N">Influenza A Virus, H9N2 Subtype</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010843" MajorTopicYN="N">Pichia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19897044</ArticleId><ArticleId IdType="pii">S1046-5928(09)00289-7</ArticleId><ArticleId IdType="doi">10.1016/j.pep.2009.11.001</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Iran</li></country></list><tree><noCountry><name sortKey="Attaran, Hamid Reza" sort="Attaran, Hamid Reza" uniqKey="Attaran H" first="Hamid Reza" last="Attaran">Hamid Reza Attaran</name><name sortKey="Memarnejadian, Arash" sort="Memarnejadian, Arash" uniqKey="Memarnejadian A" first="Arash" last="Memarnejadian">Arash Memarnejadian</name><name sortKey="Tebianian, Majid" sort="Tebianian, Majid" uniqKey="Tebianian M" first="Majid" last="Tebianian">Majid Tebianian</name><name sortKey="Toghyani, Hadi" sort="Toghyani, Hadi" uniqKey="Toghyani H" first="Hadi" last="Toghyani">Hadi Toghyani</name></noCountry><country name="Iran"><noRegion><name sortKey="Ebrahimi, Seyyed Mahmoud" sort="Ebrahimi, Seyyed Mahmoud" uniqKey="Ebrahimi S" first="Seyyed Mahmoud" last="Ebrahimi">Seyyed Mahmoud Ebrahimi</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000191 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000191 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19897044
|texte= Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19897044" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |